Zacks Research Estimates Neogen's Q2 Earnings (NASDAQ:NEOG)

Key Points

• Zacks Research cut Neogen’s Q2 2027 earnings estimate to $0.06 per share from $0.08, while the full-year consensus estimate stands at $0.28 per share.
• Analyst sentiment remains mixed: three analysts rate Neogen a Buy, one a Hold, and one a Sell, resulting in an average “Hold” rating and a consensus price target of $12.67.
• Neogen recently exceeded quarterly expectations, reporting $0.08 EPS versus the $0.05 consensus and revenue of $222.8 million, up 6.5% year over year.

Neogen Corporation (NASDAQ:NEOG - Free Report) - Investment analysts at Zacks Research decreased their Q2 2027 earnings estimates for shares of Neogen in a report issued on Tuesday, October 27th. Zacks Research analyst Team now forecasts that the company will earn $0.06 per share for the quarter, down from their prior estimate of $0.08. The consensus estimate for Neogen's current full-year earnings is $0.28 per share. Zacks Research also issued estimates for Neogen's Q1 2028 earnings at $0.07 EPS.

A number of other analysts have also recently commented on the stock. Weiss Ratings upgraded shares of Neogen from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 7th. Piper Sandler upgraded Neogen from a "neutral" rating to an "overweight" rating and upped their price objective for the stock from $13.00 to $14.00 in a research note on Wednesday, August 26th. Wall Street Zen downgraded Neogen from a "strong-buy" rating to a "buy" rating in a research report on Sunday, October 11th. Finally, Guggenheim reaffirmed a "buy" rating and set a $14.00 target price (up from $12.00) on shares of Neogen in a report on Wednesday, September 30th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $12.67.

Neogen Stock Performance

Shares of NASDAQ:NEOG opened at $12.26 on Friday. The firm's 50 day simple moving average is $12.23 and its 200 day simple moving average is $10.41. Neogen has a fifty-two week low of $5.37 and a fifty-two week high of $14.26. The company has a market capitalization of $2.68 billion, a price-to-earnings ratio of -49.04, a P/E/G ratio of 4.33 and a beta of 1.79. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.90 and a quick ratio of 2.92.

Neogen (NASDAQ:NEOG - Get Free Report) last announced its quarterly earnings data on Tuesday, October 6th. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Neogen had a positive return on equity of 3.29% and a negative net margin of 6.35%. The business had revenue of $222.80 million during the quarter, compared to analysts' expectations of $208.18 million. During the same period in the previous year, the firm earned $0.04 earnings per share. The firm's quarterly revenue was up 6.5% compared to the same quarter last year.

Institutional Investors Weigh In On Neogen

Several hedge funds and other institutional investors have recently bought and sold shares of NEOG. Canton Hathaway LLC purchased a new stake in shares of Neogen in the third quarter worth approximately $26,000. Farther Finance Advisors LLC boosted its position in shares of Neogen by 76.1% during the third quarter. Farther Finance Advisors LLC now owns 2,184 shares of the company's stock valued at $28,000 after buying an additional 944 shares during the last quarter. Nykredit A S bought a new stake in Neogen during the second quarter worth $28,000. Public Employees Retirement System of Ohio purchased a new stake in Neogen in the 2nd quarter valued at $34,000. Finally, Integrated Wealth Concepts LLC bought a new position in Neogen during the 2nd quarter valued at $73,000. 96.73% of the stock is owned by institutional investors.

About Neogen

Neogen Corporation develops and markets products and services designed to help protect the food supply and support animal health. Its food safety offerings include diagnostic tests and laboratory products used to detect pathogens, allergens, mycotoxins, genetically modified organisms, veterinary drug residues, and other contaminants in food and agricultural environments.

The company also provides sanitation and hygiene products, environmental monitoring solutions, and software and data-management tools that help food processors, retailers, laboratories, and other organizations manage food safety programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.